| 8190756 |
Method for automatically re-connecting customer premises equipment (CPE) web user interface (UI) |
— |
2012-05-29 |
|
| 8151184 |
Method for promoting the accessing efficiency with embedded web page |
— |
2012-04-03 |
|
| 6498168 |
Muscarinic antagonists |
Derek Lowe, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade, Allen Barnett +14 more |
2002-12-24 |
$316,470,000 |
| 6288068 |
Muscarinic antagonists |
Derek Lowe, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade, Allen Barnett +14 more |
2001-09-11 |
|
| 6043255 |
Muscarinic antagonists |
Derek Lowe, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade, Allen Barnett +15 more |
2000-03-28 |
$211,491,000 |
| 6037352 |
Muscarinic antagonists |
Derek Lowe, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade, Allen Barnett +14 more |
2000-03-14 |
$302,746,000 |
| 5977138 |
Ether muscarinic antagonists |
Yuguang Wang, Sundeep Dugar, Samuel Chackalamannil |
1999-11-02 |
$230,584,000 |
| 5935958 |
Muscarinic antagonists |
Joseph A. Kozlowski, Derek Lowe, Sundeep Dugar |
1999-08-10 |
$137,302,000 |
| 5889006 |
Muscarinic antagonists |
Derek Lowe, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade, Allen Barnett +15 more |
1999-03-30 |
$271,440,000 |
| 5883096 |
Muscarinic antagonists |
Derek Lowe, Joseph A. Kozlowski, Joel G. Berger, Robert McQuade, Allen Barnett +14 more |
1999-03-16 |
$290,907,000 |
| 5530125 |
Synthesis of .alpha.-substituted-aryl ethylamines |
Joel G. Berger, Joseph A. Kozlowski, Guowei Zhou |
1996-06-25 |
$112,344,000 |
| 5440033 |
Indolyl-, pyrrolyl- and pyrazolyl substituted benzazepines |
Joel G. Berger, Joseph A. Kozlowski |
1995-08-08 |
$36,709,000 |
| 5374722 |
Bridged benzazepines |
Joel G. Berger, John W. Clader |
1994-12-20 |
$63,604,000 |
| 5302716 |
Fused benzazepines |
Joel G. Berger, Elijah H. Gold, John W. Clader |
1994-04-12 |
$61,685,000 |
| 5247080 |
Substituted benzazepines useful as intermediates for producing pharmaceutically active compounds |
Joel G. Berger, Marjorie Peters |
1993-09-21 |
$87,741,000 |
| 5241065 |
2,3,4,5-tetrahydro-1H-3-benzazepines having anti-psychotic activity |
Joel G. Berger, Joseph A. Kozlowski, Guowei Zhou |
1993-08-31 |
$82,198,000 |
| 5015639 |
Substituted benzazepines, their preparation and pharmaceutical compositions containing them |
Joel G. Berger, Marjorie Peters |
1991-05-14 |
$34,046,000 |
| 4996202 |
1,2,4,5 tetrahydro benzazepine-3 compounds and antipsychotic use thereof |
Joel G. Berger, Elijah H. Gold, Arthur J. Elliott |
1991-02-26 |
$31,037,000 |
| 4973586 |
Fused benzazepines, compositions of, and medical use thereof |
Joel G. Berger, Elijah H. Gold, John W. Clader |
1990-11-27 |
$17,753,000 |
| 4950783 |
Treatment of hypertension |
Elijah H. Gold |
1990-08-21 |
$38,809,000 |
| 4658060 |
Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide |
Elijah J. Gold, Esther Babad, Lydia Peer |
1987-04-14 |
$14,675,000 |
| 4619919 |
Treatment of hypertension |
Elijah H. Gold |
1986-10-28 |
$28,723,000 |
| 4477378 |
Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
Elijah H. Gold |
1984-10-16 |
$9,343,000 |
| 4349472 |
(S)-8(1-Adamantanecarbonyloxy)-7-chloro-3-methyl-1-phenyl-2,3,4, 5-tetrahydro-1H-3-benzazepine |
Elijah H. Gold |
1982-09-14 |
$6,106,000 |
| 4340597 |
1-Substituted-4-aryl-1,2,5,6-tetrahydro and hexahydropyridines |
Elijah H. Gold, Joel G. Berger |
1982-07-20 |
$10,004,000 |